AI CAPITAL INTELLIGENCE

BigHat Biosciences funding history

1 recorded financing disclosures for BigHat Biosciences. Dates, rounds, currencies and original sources follow the individual records. This is not a complete company funding history.

Latest recorded funding, at a glance

The latest disclosure recorded for BigHat Biosciences is dated 2026-09-24: Series C, USD 75,000,000. Named investors: DFJ Growth, Premji Invest, Catalio Capital Management, LG Technology Ventures, Sigmas Group, 8VC, Alexandria Venture Investments, Amgen Ventures, Andreessen Horowitz (a16z), Discovery Ventures, GRIDS Capital, Intermountain Ventures, Eli Lilly and Company, Merck Global Health Innovation Fund, Quadrille Capital, Section 32. This is the latest record in our coverage, not a claim about all company financing.

Verify this disclosure · Original source 1 · Original source 2

Disclosures and evidence

Disclosure dateRoundDisclosed amountNamed investorsEvidence
Series CUSD 75,000,000DFJ Growth, Premji Invest, Catalio Capital Management, LG Technology Ventures, Sigmas Group, 8VC, Alexandria Venture Investments, Amgen Ventures, Andreessen Horowitz (a16z), Discovery Ventures, GRIDS Capital, Intermountain Ventures, Eli Lilly and Company, Merck Global Health Innovation Fund, Quadrille Capital, Section 32Record · Source 1 · Source 2

Recorded financing disclosures

Disclosed investors across recorded rounds

Publicly disclosed founding team

Browse companies